Scinovex
article Open AccessTop 10% cited

Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features

Bioorganic & Medicinal Chemistry · 2006 · Vol. 14(24) · pp. 8295–8306
Lili ChenJian LiCheng LuoHong LiuWeijun XuGang ChenOi Wah LiewWeiliang ZhuChum Mok PuahXu ShenHualiang Jiang
Computational Drug Discovery MethodsSynthesis and biological activityBioactive Compounds and Antitumor AgentsChemistryPharmacophoreStereochemistryStructure–activity relationshipMoietyDrug discoveryNatural productQuercetinMolecular modelBiochemistry

MeSH terms

Coronavirus 3C ProteasesBinding SitesCysteine EndopeptidasesHumansModels, MolecularProtease InhibitorsQuercetinStructure-Activity RelationshipViral ProteinsDrug DesignMolecular StructureSevere acute respiratory syndrome-related coronavirus

Funding

  • National Key Research and Development Program of China
Citations
268
FWCI
4.74
field-weighted impact
References
43
Percentile
95%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features · Scinovex